Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,97 USD | -7,96% | -43,97% | -69,98% |
12/04 | Sectorupdate: Gezondheidszorgaandelen dalen laat in de middag | MT |
12/04 | Sectorupdate: Gezondheidszorg | MT |
Vakgebied
Aantal werknemers: 389
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Non-cash Royalties
73,3
%
| 45 | 46,2 % | 115 | 73,3 % | +153,00% |
License Fees and Milestones
16,0
%
| 5 | 5,1 % | 25 | 16,0 % | +400,00% |
Deferred Research and Development
7,8
%
| 10 | 9,7 % | 12 | 7,8 % | +28,06% |
Other
1,9
%
| 11 | 10,7 % | 3 | 1,9 % | -71,68% |
Research and Development
0,9
%
| 2 | 1,7 % | 1 | 0,9 % | -14,38% |
Clinical Product
0,1
%
| 1 | 0,8 % | 0 | 0,1 % | -84,78% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
98,1
%
| 88 | 89,3 % | 153 | 98,1 % | +75,22% |
Rest of World
1,9
%
| 11 | 10,7 % | 3 | 1,9 % | -71,68% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 31-03-94 |
Director of Finance/CFO | 58 | 01-01-96 | |
Craig Winter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steven O’Day
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-21 |
Homa Yeganegi
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-23 |
Zack Armen
IRC | Investor Relations Contact | - | 01-12-22 |
Human Resources Officer | - | - | |
Eric Humes
PRN | Corporate Officer/Principal | - | 01-01-22 |
Alfred Dadson
PRN | Corporate Officer/Principal | - | 01-01-16 |
Robin Taylor
PRN | Corporate Officer/Principal | - | 20-07-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 31-03-94 |
Director/Board Member | 66 | 17-05-16 | |
Susan Hirsch
BRD | Director/Board Member | 71 | 08-10-20 |
Brian Corvese
BRD | Director/Board Member | 67 | 08-03-07 |
Director/Board Member | 58 | 07-11-18 | |
Timothy Wright
BRD | Director/Board Member | 66 | 07-12-06 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 31 620 | 0 | 0 | 98,80 % |
Aandeel B | 1 | 20 946 003 | 20 695 298 ( 98,80 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
MINK THERAPEUTICS, INC. 62.75% | 21 772 863 | 62.75% | 19 769 760 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-69,98% | 104 mln. | |
-1,82% | 41,35 mld. | |
+41,70% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |
- Beurs
- Aandelen
- Koers AGEN
- Onderneming Agenus Inc.